Ardent Health Partners, LLC (NYSE:ARDT) Given Consensus Recommendation of “Buy” by Brokerages

Shares of Ardent Health Partners, LLC (NYSE:ARDT) have been assigned an average recommendation of “Buy” from the thirteen brokerages that are currently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, nine have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1 year target price among analysts that have covered the stock in the last year is $20.58.

Several research firms have weighed in on ARDT. Royal Bank of Canada decreased their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a report on Tuesday, March 4th. Truist Financial lowered their price objective on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Guggenheim began coverage on Ardent Health Partners in a research report on Wednesday, April 9th. They issued a “buy” rating and a $16.00 target price on the stock. Stephens reiterated an “overweight” rating and set a $22.00 price target on shares of Ardent Health Partners in a report on Tuesday, April 1st. Finally, Mizuho reduced their price objective on shares of Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, April 9th.

Ardent Health Partners Stock Performance

Ardent Health Partners stock opened at $12.50 on Friday. The company has a fifty day simple moving average of $13.61 and a 200-day simple moving average of $15.57. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. Ardent Health Partners has a 52-week low of $11.60 and a 52-week high of $20.72.

Ardent Health Partners (NYSE:ARDT) last issued its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.31. The company had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.48 billion. As a group, sell-side analysts predict that Ardent Health Partners will post 1.23 EPS for the current year.

Institutional Trading of Ardent Health Partners

Large investors have recently modified their holdings of the stock. Ventas Inc. purchased a new stake in Ardent Health Partners during the 4th quarter worth about $159,570,000. Franklin Resources Inc. purchased a new stake in shares of Ardent Health Partners in the 3rd quarter valued at approximately $15,839,000. Segall Bryant & Hamill LLC acquired a new stake in shares of Ardent Health Partners in the 4th quarter valued at $4,478,000. Pier Capital LLC lifted its position in shares of Ardent Health Partners by 70.1% during the 4th quarter. Pier Capital LLC now owns 373,904 shares of the company’s stock worth $6,386,000 after purchasing an additional 154,077 shares during the last quarter. Finally, Geode Capital Management LLC acquired a new position in shares of Ardent Health Partners during the third quarter worth $2,581,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.